Cubist Systematic Strategies, LLC T2 Biosystems, Inc. Transaction History

Cubist Systematic Strategies, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$0.86 - $1.21 $85,393 - $120,146	-99,295 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$1.04 - $1.69 $39,732 - $64,564	38,204 Added 62.54%	99,295 $118,000
Q1 2021 May 17, 2021	BUY	$1.32 - $3.79 $80,640 - $231,534	61,091 New	61,091 $99,000
Q3 2019 Nov 14, 2019	SELL	$0.58 - $3.01 $633 - $3,289	-1,093 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$2.56 - $4.48 $2,708 - $4,739	-1,058 Reduced 49.19%	1,093 $3,000
Q4 2018 Feb 14, 2019	SELL	$2.98 - $6.86 $12,325 - $28,372	-4,136 Reduced 65.79%	2,151 $6,000
Q3 2018 Nov 14, 2018	BUY	$5.36 - $7.83 $32,626 - $47,661	6,087 Added 3043.5%	6,287 $47,000
Q2 2018 Aug 14, 2018	SELL	$5.97 - $9.58 $5,373 - $8,622	-900 Reduced 81.82%	200 $2,000
Q1 2018 May 15, 2018	BUY	$4.21 - $7.0 $4,631 - $7,700	1,100 New	1,100 $7,000

Ticker TTOO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 7,050,850
Market Cap $5.99M
Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.